Cliniboosta has established strategic partnerships with multiple top-tier CROs, SMOs, data statistics providers, and central laboratories in China. This integrated network forms a comprehensive clinical trial supply chain system that ensures seamless coordination and maximizes efficiency across all stages of clinical research.
CRO – Global Compliance Assurance:
Our CRO partners offer end-to-end services including site activation, protocol design, ethics committee submissions, patient recruitment, clinical monitoring, and data management. All processes strictly adhere to China, U.S., UK, and EU GCP standards, as well as international requirements for bridging studies, laying a solid foundation for the global translation of innovative therapies.
SMO – On-site Operational Synergy:
SMO collaborations optimize multi-center trial operations, delivering significant improvements in key performance indicators. For example, in a rare disease study, the site activation cycle was shortened by 30%, substantially reducing internal resource consumption and accelerating study progression.
Central Lab – Advanced Technology Integration:
Through partnerships with authoritative central laboratories, we incorporate cutting-edge technologies such as genetic sequencing and molecular pathology. These labs generate standardized biospecimen data under international quality control, providing reliable data support for bridging studies and global registration.
